Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

Publication | Closed Access

DOI

388

Citations

References

2018

Year

Gary T. Ferguson, Klaus F. Rabe, Fernando J. Martínez, Leonardo M. Fabbri, Chen Wang, Masakazu Ichinose, Eric Bourne, Shaila Ballal, Patrick Darken, Kiernan DeAngelis,

The Lancet Respiratory Medicine

Translational MedicinePulmonary CareAdvanced Lung DiseaseTriple TherapyPulmonary PharmacologyBudesonide/glycopyrrolate/formoterol FumaratePulmonary MedicinePharmacotherapyMedicinePulmonary DiseasePhase 3